Preventing Medication Errors

A 2006 Institute of Medicine report stated that the annual cost of hospital medication error is estimated to be $3.5 billion.1 Between 2003-2006, 25,530 look-alike/sound-alike errors were reported, with a significant number due to labeling and packaging.2

Ameridose can help reduce the potential for medication error in your facility since the preparations that we deliver address ASHP-cited risk factors. For example, we provide preparations in pre-dosed, ready-to-use form; product name and strength are the outstanding focus of our labeling; we follow recommended conventions for look-alike/sound-alike differentiation with TALL-man lettering, as well as conventions to differentiate high-alert medications.

Patient safety is built into our preparation labeling and packaging. Our preparation labeling enables outstanding ease of identification as well as compliance with Joint Commission National Patient Safety Goals regarding proper medication labeling and label differentiation of look-alike, sound-alike and high-alert medications.
  • Over-sized font to broadcast medication name and strength
  • Special safety labeling conventions that help to differentiate:
    • Look-alike, sound-alike medications
    • High and low concentrations
    • High risk medications such as Heparin
  • Bold, ISMP-recommended TALL-man lettering
  • Lot number and expiration date prominently placed
  • American Society of Anesthesiologists-endorsed ASTM color-coding by drug class
  • OR syringes featuring medication name in horizontal and vertical formats
  • NDC barcoding
  • Addressing new ISMP guidelines:
    • "Unit" written out on labels to avoid confusion of the letter “u” with a zero or four
    • Zero used before the decimal point when the dose is less than a whole unit
    • Ample space provided between drug name, dose, and unit of measure
    • Commas used to clarify dosing units of 1,000 or more

Patient safety is built into our manufacturing processes, giving you confidence that you are providing the very best preparations for your patients.
  • An FDA registered manufacturer, Ameridose follows USP <797> standards and meets cGMP requirements utilizing commercially available sterile drug components and containers.
  • Licensed pharmacists supervise our certified and registered technicians throughout preparation and are responsible for verifying and releasing all final products.
  • Ameridose's stability testing and special processes allow us to provide you with exceptional shelf life. Our stability testing is done through FDA-registered third-party laboratories, evaluating extensive criteria including potency, sterility, pH, and particulate matter.
  • Process controls ensure absolute accuracy of labeled drug and strength.
  • Preparations are dispensed in ready-to-use unit doses.
  • Many of our preparations are sealed with tamper-evident caps and UV-resistant safety overwrap bags for added protection and security.

1. Aspden P, Wolcott J, Bootman JL, Cronenwett LR (eds). 2006. Committee on Identifying and Preventing Medication Errors: Preventing Medication Errors: Quality Chasm Series. Institute of Medicine of the National Academies, Washington, National Academy Press. pp.112, 117.

2. Hicks, RW, Becker, SC, Cousins, DD (eds). 2008. MEDMARX data report. Rockville, MD: Center for the Advancement of Patient Safety, US Pharmacopeia.
All contents © copyright  Ameridose, LLC. All rights reserved.